Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
PL Intelligence
Reports
Partnering Consulting
Due Diligence
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Corporation
Partnering Support

Latest updates

Health Care 2009 Report

On June 25th, UTEK Corporation, parent of pharmalicensing.com and a leading innovation services company, and The wRatings Corporation, an independent stock research firm, released the results of their annual Most Competitive Companies in Health Care Study. The study was conducted in a collaborative effort between The wRatings Corporation and Strategos, a strategic innovation consulting division of UTEK. Major highlights from the study include a 70% turnover of the Top 20 Companies and Johnson & Johnson moving from #3 to #1, followed by Alcon and Eli Lilly. The largest jump was Cardinal Health, rising from #83 to #12.

Scores from wRatings are a blend of how well companies meet customer expectations while also generating economic profit. The quarterly survey is conducted with a representative sample of US consumers and business executives.

The annual report and Top 20 list is available at www.strategos.com. Full data are available to wRatings (www.wratings.com) subscribers.

Click here to download the report.

Visit Pharmalicensing at the Euro-Biotech Forum 2009

Windhover Information's annual Euro-Biotech Forum - celebrating its 16th successful year, and its second in beautiful Barcelona, Spain. Windhover Information's Euro-Biotech Forum is the best global partnering meeting for American and European life science companies, with the highest concentration of senior level biopharma executives. Euro-Biotech Forum features Windhover editorial teams' plenary discussions and one-on-one meetings.

Pharmalicensing will be attending this esteemed event this year and would be happy to meet with anyone interested in finding out more about its services. If you would like to meet with Pharmalicensing then please contact us through Windhover's partnering software.

  • Find out more and register for Euro Biotech 2009
  • Contact us to arrange a meeting or call us on +44 1904 520460

Collaborating to address the future of innovation

Pharmalicensing is pleased to announce the launch of a new website, http://thefutureofinnovation.org. The initiative represents a unique project which was conceived by innovation experts Drs. Bettina von Stamm, UK and Anna Trifilova, Russia and is proudly sponsored by Pharmalicensing.

The Future of Innovation website along with its sister publication of the same name which is to be released by Gower Books this Autumn, represents a community of over 350 leading thinkers in over 60 countries from business, government, consulting and academia who are sharing their thoughts, experiences, dreams, visions, hopes, concerns, and passions around the future of innovation.

 

Clients in focus...

Get the Flash Player to see this rotator.

What's New In...

Our Products

PL Intelligence

PLi Logo
Categorised to your specific requirements PL Intelligence is your personalised source of:
  • industry news
  • deals
  • latest partnering opportunities
  • best selling reports
PL Intelligence

In-licensing

OTC products to treat Foot Infections

In licensing needs: Seeking opportunities for OTC consumer healthcare products for the treatment of infections affecting the foot. More

View more in-licensing needs

Out-licensing

Prevention and Treatment of Multiple Sclerosis (MS) by Administering E-Selectin

A method and composition for inhibiting or treating symptoms of inflammatory demyelination or inflammation associated with autoimmune disorders. More

View more out-licensing opportunities

Companies

Yissum Technology Transfer Company of the Hebrew University of Jerusalem

Yissum protects, promotes and markets the technologies and expertise of the University of Jerusalem More

View more profiled companies

In the Spotlight...

SSL International

SSL International plc is a manufacturer and distributor of healthcare products sold into consumer markets worldwide.

SSL has a diverse portfolio of consumer products which include Durex (condoms and personal lubricants) and Scholl (footcare and footwear).

Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us